MAC UK   Report issue

For profit Phase 1 Phase 2

Organization Overview

First Clinical Trial
2020
NCT04686916
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

MAC UK

Active Ingredients

Drugs in Phase 2 Trials (2)

ip2018 (1 trial)

Pudafensine (1 trial)

Drugs in Phase 1 Trials (2)

fluconazole (diflucan) (2 trials)

pregabalin (lyrica) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erectile Dysfunction (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4